GlaxoSmithKline reportedly looking to sell select antibiotic brands - PMLiVE
Buy, Sell or Hold: GlaxoSmithKline PLC (GSK-N) — Stock Predictions at Stockchase
GlaxoSmithKline and Pfizer to Merge Consumer Health Units - The New York Times
GSK: Glaxo SmithKline Share Price Target 2023, 2025, 2027, 2030 to 2050 - Sharedhan
GSK plc - Wikipedia
FTSE 100: GSK Reaches Settlement in Zantac Lawsuit | Markets Insider
With $1.2B stock sale, GSK offloads more of its stake in consumer health spinoff Haleon | Fierce Pharma
GSK plc (NYSE:GSK) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
GSK Raises $1 Billion Selling Shares in Haleon Spinoff - Bloomberg
Glaxo plots £8bn move to buy back Beechams stake
With 83% ownership of the shares, GSK plc (LON:GSK) is heavily dominated by institutional owners - Simply Wall St News
Is GSK a Strong Buy Right Now? | The Motley Fool
GSK shares: Price analysis before buying or selling
GSK Raises Almost £1 Billion by Selling Another Haleon Stake - Bloomberg
A GSK Dividend Cut Is Imminent - Should I Sell GlaxoSmithKline? - TEV
GSK (GSK) Declines More Than Market: Some Information for Investors
GSK bets on cough drug with $2bn deal for Canadian biotech
GSK (GSK) is a Top-Ranked Value Stock: Should You Buy?
GSK agrees £9bn deal for consumer healthcare stake – and may sell Horlicks to buy it
Pfizer Changes Its Mind, Will Sell Down Stake in GSK's Haleon Unit - Investing.com India
GSK Lifts Annual Outlook as Q3 Vaccine Sales Soar - TipRanks.com
GlaxoSmithKline Stock Forecast | Is GlaxoSmithKline a Good Stock to Buy?
GSK To Sell Poznań Manufacturing Site To Delpharm | Contract Pharma
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BWRRND7NK5ORFONQ4YXBCQPDTU.jpg "GSK raises $1.24 bln from latest Haleon stake sale | Reuters")
GSK raises $1.24 bln from latest Haleon stake sale | Reuters
GSK slapped with 'sell' rating over long-term risks | LSE:GSK, NYSE:GSK
